Gonzalez R, Massman L, Ho S, Luna S, Cheok S, Liang B
Pituitary. 2024; 27(5):577-589.
PMID: 39066842
DOI: 10.1007/s11102-024-01431-x.
Alsavaf M, Wu K, Finger G, Salem E, Castello Ruiz M, Godil S
J Neurosurg Case Lessons. 2023; 5(20).
PMID: 37212418
PMC: 10550526.
DOI: 10.3171/CASE2350.
Sabatino M, Grondona E, De Paul A
Front Endocrinol (Lausanne). 2022; 13:924942.
PMID: 35837315
PMC: 9273718.
DOI: 10.3389/fendo.2022.924942.
Zhao S, He Y, Wang H, Li D, Gong L, Zhang Y
Front Endocrinol (Lausanne). 2022; 13:863017.
PMID: 35634489
PMC: 9130458.
DOI: 10.3389/fendo.2022.863017.
Jiang S, Chen X, Wu Y, Wang R, Bao X
Cancers (Basel). 2021; 13(23).
PMID: 34885244
PMC: 8656508.
DOI: 10.3390/cancers13236134.
Aggressive Cushing's Disease: Molecular Pathology and Its Therapeutic Approach.
Yamamoto M, Nakao T, Ogawa W, Fukuoka H
Front Endocrinol (Lausanne). 2021; 12:650791.
PMID: 34220707
PMC: 8242934.
DOI: 10.3389/fendo.2021.650791.
Recent Understanding and Future Directions of Recurrent Corticotroph Tumors.
Hinojosa-Amaya J, Lam-Chung C, Cuevas-Ramos D
Front Endocrinol (Lausanne). 2021; 12:657382.
PMID: 33986726
PMC: 8111286.
DOI: 10.3389/fendo.2021.657382.
Clinical Parameters of Silent Corticotroph Adenomas With Positive and Negative Adrenocorticotropic Hormone Immunostaining: A Large Retrospective Single-Center Study of 105 Cases.
Zhang K, Shou X, Chen H, Qiao N, He W, Chen Z
Front Endocrinol (Lausanne). 2021; 11:608691.
PMID: 33584540
PMC: 7873875.
DOI: 10.3389/fendo.2020.608691.
The silent variants of pituitary tumors: demographic, radiological and molecular characteristics.
Torregrosa-Quesada M, Garcia-Martinez A, Sanchez-Barbie A, Silva-Ortega S, Camara R, Fajardo C
J Endocrinol Invest. 2021; 44(8):1637-1648.
PMID: 33476035
DOI: 10.1007/s40618-020-01468-2.
Clinical, Laboratory, and Treatment Profiles of Silent Corticotroph Adenomas That Have Transformed to the Functional Type: A Case Series With a Literature Review.
Zheng G, Lu L, Zhu H, You H, Feng M, Liu X
Front Endocrinol (Lausanne). 2020; 11:558593.
PMID: 33071973
PMC: 7538591.
DOI: 10.3389/fendo.2020.558593.
Corticotroph (Basophil) invasion of the pars nervosa in the human pituitary: Localization of proopiomelanocortin peptides, galanin and peptidylglycine α-amidating monooxygenase-like immunoreactivities.
Lloyd R, DAmato C, Thiny M, Jin L, Hicks S, Chandler W
Endocr Pathol. 2020; 4(2):86-94.
PMID: 32138413
DOI: 10.1007/BF02914457.
Postoperative expression of Cushing disease in a young male: metamorphosis of silent corticotroph adenoma?.
Jahan S, Hasanat M, Mahmood T, Morshed S, Haq R, Fariduddin M
Endocrinol Diabetes Metab Case Rep. 2019; 2019.
PMID: 31671410
PMC: 6790907.
DOI: 10.1530/EDM-19-0046.
Recent advances in understanding corticotroph pituitary tumor initiation and progression.
Renner U, Ciato D, Stalla G
F1000Res. 2018; 7.
PMID: 30228864
PMC: 6117851.
DOI: 10.12688/f1000research.14789.1.
Clinical and Pathological Aspects of Silent Pituitary Adenomas.
Drummond J, Roncaroli F, Grossman A, Korbonits M
J Clin Endocrinol Metab. 2018; 104(7):2473-2489.
PMID: 30020466
PMC: 6517166.
DOI: 10.1210/jc.2018-00688.
Aggressive somatotrophinomas lacking clinical symptoms: neurosurgical management.
Giordano M, Samii A, Fahlbusch R
Neurosurg Rev. 2018; 41(4):999-1005.
PMID: 29290044
DOI: 10.1007/s10143-017-0940-y.
Predictors of silent corticotroph adenoma recurrence; a large retrospective single center study and systematic literature review.
Langlois F, Lim D, Yedinak C, Cetas I, McCartney S, Cetas J
Pituitary. 2017; 21(1):32-40.
PMID: 29032459
DOI: 10.1007/s11102-017-0844-4.
Prognostic significance of corticotroph staining in radiosurgery for non-functioning pituitary adenomas: a multicenter study.
Cohen-Inbar O, Xu Z, Lee C, Wu C, Chytka T, Silva D
J Neurooncol. 2017; 135(1):67-74.
PMID: 28913674
PMC: 5817983.
DOI: 10.1007/s11060-017-2520-y.
The changing faces of corticotroph cell adenomas: the role of prohormone convertase 1/3.
Righi A, Faustini-Fustini M, Morandi L, Monti V, Asioli S, Mazzatenta D
Endocrine. 2016; 56(2):286-297.
PMID: 27491554
DOI: 10.1007/s12020-016-1028-0.
The Complementary Role of Transcription Factors in the Accurate Diagnosis of Clinically Nonfunctioning Pituitary Adenomas.
Nishioka H, Inoshita N, Mete O, Asa S, Hayashi K, Takeshita A
Endocr Pathol. 2015; 26(4):349-55.
PMID: 26481628
DOI: 10.1007/s12022-015-9398-z.
Transformation of a Silent Adrencorticotrophic Pituitary Tumor Into Central Nervous System Melanoma.
Miller B, Tanaka T, Ioachimescu A, Vincentelli C, Appin C, Oyesiku N
J Investig Med High Impact Case Rep. 2015; 1(2):2324709613494008.
PMID: 26425577
PMC: 4528794.
DOI: 10.1177/2324709613494008.
